haku: @author Calfee, J. E. / yhteensä: 2
viite: 1 / 2
« edellinen | seuraava »
| Tekijä: | Calfee, J. E. |
| Otsikko: | Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs |
| Lehti: | Journal of Public Policy and Marketing
2002 : FALL, VOL. 21:2, p. 174-193 |
| Asiasana: | PUBLIC POLICY DIRECT SELLING ADVERTISING PHARMACEUTICAL INDUSTRY |
| Kieli: | eng |
| Tiivistelmä: | In August 1997, the Food and Drug Administration (FDA) announced a reinterpretation of its rules on direct- to-consumer (DTC) advertising, the effect of which was to permit branded broadcast advertisements and therefore to increase the volume of DTC advertising several-fold, A substantial body of research, consisting primarily of consumer surveys, provides the basis for a preliminary assessment of the effects of DTC advertisements. The FDA 's own assessment, that DTC advertisements can provide substantial benefits and do not appear to cause substantial harm, is consistent with survey and other data. The author suggests that a further relaxation of FDA rules would accelerate the dissemination of valuable information, with favorable consequences for drug development and consumer health. |
« edellinen | seuraava »
SCIMA